Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in Intestinal Morphology in Male Sprague–Dawley Rats But Aflibercept Affects Serum and Urine Metabolic Profiles
- DOI
- 10.1016/j.tranon.2019.04.019
- Published
- 2019-08
- Container
- Translational Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.tranon.2019.04.019,
title = {Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in Intestinal Morphology in Male Sprague–Dawley Rats But Aflibercept Affects Serum and Urine Metabolic Profiles},
author = {Richard A. Forsgård and Vannina G Marrachelli and Jere Lindén and Rafael Frias and Maria Carmen Collado and Riitta Korpela and Daniel Monleon and Thomas Spillmann and Pia Österlund},
year = {2019},
journal = {Translational Oncology},
doi = {10.1016/j.tranon.2019.04.019},
url = {https://doi.org/10.1016/j.tranon.2019.04.019}
}RIS
TY - JOUR TI - Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in Intestinal Morphology in Male Sprague–Dawley Rats But Aflibercept Affects Serum and Urine Metabolic Profiles AU - Richard A. Forsgård AU - Vannina G Marrachelli AU - Jere Lindén AU - Rafael Frias AU - Maria Carmen Collado AU - Riitta Korpela AU - Daniel Monleon AU - Thomas Spillmann AU - Pia Österlund PY - 2019 JO - Translational Oncology DO - 10.1016/j.tranon.2019.04.019 UR - https://doi.org/10.1016/j.tranon.2019.04.019 ER -
APA
Forsgård, R. A., Marrachelli, V. G., Lindén, J., Frias, R., Collado, M. C., Korpela, R., Monleon, D., Spillmann, T., & Österlund, P. (2019). Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in Intestinal Morphology in Male Sprague–Dawley Rats But Aflibercept Affects Serum and Urine Metabolic Profiles. Translational Oncology. https://doi.org/10.1016/j.tranon.2019.04.019
Source records
- crossref · retrieved 2026-09-25T12:56:24.877Z